Bruker Corporation – NASDAQ:BRKR
Bruker stock price today
$34.1
-24.30
-41.62%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Bruker stock price monthly change
-9.79%
month
Bruker stock price quarterly change
-9.79%
quarter
Bruker stock price yearly change
-20.67%
year
Bruker key metrics
Market Cap | 8.65B |
Enterprise value | 11.00B |
P/E | 28.37 |
EV/Sales | 3.39 |
EV/EBITDA | 20.62 |
Price/Sales | 2.73 |
Price/Book | 4.73 |
PEG ratio | 2.55 |
EPS | 2.75 |
Revenue | 3.00B |
EBITDA | 536.2M |
Income | 401.6M |
Revenue Q/Q | 5.31% |
Revenue Y/Y | 14.49% |
Profit margin | 9.41% |
Oper. margin | 10.13% |
Gross margin | 48.88% |
EBIT margin | 10.13% |
EBITDA margin | 17.87% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBruker stock price history
Bruker stock forecast
Bruker financial statements
Average Price Target
$76.67
Potential upside: 124.82%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 681.9M | 57.1M | 8.37% |
|---|---|---|---|
| Sep 2023 | 742.8M | 88.1M | 11.86% |
| Dec 2023 | 854.5M | 205.5M | 24.05% |
| Mar 2024 | 721.7M | 50.9M | 7.05% |
0.34%
Yield TTM
| Payout ratio | 9.81% |
|---|
| 2019 | 0.32% |
|---|---|
| 2020 | 0.3% |
| 2021 | 0.19% |
| 2022 | 0.29% |
| 2023 | 0.27% |
| Jun 2023 | 3857000000 | 2.59B | 67.26% |
|---|---|---|---|
| Sep 2023 | 3818200000 | 2.57B | 67.41% |
| Dec 2023 | 4249899999 | 2.83B | 66.75% |
| Mar 2024 | 4506400000 | 3.05B | 67.81% |
| Jun 2023 | 13M | -26M | -10.3M |
|---|---|---|---|
| Sep 2023 | 44.1M | -155M | -92.5M |
| Dec 2023 | 205.5M | -37.3M | -59.9M |
| Mar 2024 | 21.8M | -305.1M | 152.6M |
Bruker alternative data
| Sep 2023 | 8,525 |
|---|---|
| Oct 2023 | 8,525 |
| Nov 2023 | 8,525 |
| Dec 2023 | 8,525 |
| Jan 2024 | 8,525 |
| Feb 2024 | 8,525 |
| Mar 2024 | 9,707 |
| Apr 2024 | 9,707 |
| May 2024 | 9,707 |
| Jun 2024 | 9,707 |
| Jul 2024 | 9,707 |
Bruker other data
100.00%
0.00%
of BRKR is owned by hedge funds
254
-31
94.36M
-8.21M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 43441 |
| Mar 2024 | 0 | 15000 |
| Aug 2024 | 0 | 4684 |
| Nov 2024 | 100000 | 0 |
| Dec 2024 | 0 | 3350 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | PACKER RICHARD A director | Common Stock | 10,000 | $19.12 | $191,200 | ||
Sale | PACKER RICHARD A director | Common Stock | 3,350 | $57.82 | $193,684 | ||
Option | PACKER RICHARD A director | Stock Option (Right to Buy) | 10,000 | $19.12 | $191,200 | ||
Option | LINTON WILLIAM A director | Common Stock | 10,000 | $19.12 | $191,200 | ||
Option | LINTON WILLIAM A director | Stock Option (Right to Buy) | 10,000 | $19.12 | $191,200 | ||
Purchase | LAUKIEN FRANK H director, 10 perc.. | Common Stock | 3,583 | $51.36 | $184,023 | ||
Purchase | LAUKIEN FRANK H director, 10 perc.. | Common Stock | 26,551 | $50.82 | $1,349,322 | ||
Purchase | LAUKIEN FRANK H director, 10 perc.. | Common Stock | 69,866 | $49.82 | $3,480,724 | ||
Option | ROSENTHAL BOB director | Common Stock | 10,000 | $24 | $240,000 | ||
Sale | ROSENTHAL BOB director | Common Stock | 4,684 | $63.14 | $295,748 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 13 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 3 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 3 Aug 2023 | Q2 2023 Earnings Call Transcript |
Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy
Bruker Corporation Pivots To Capitalize Its Growing TAM
Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research
908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
Bruker And JEOL: Assessing The NMR Market Leaders
Bruker: Economic Principles Indicate Dislocation To Market-Implied Expectations
Bruker's Q2 2023 Triumph: Dominates Scientific Instrument Market Again
Bruker: Fundamental, Market Generated Data Corroborate Buy Thesis
Charles River Laboratories International: A Great Business At A Decent Price
-
What's the price of Bruker stock today?
One share of Bruker stock can currently be purchased for approximately $34.1.
-
When is Bruker's next earnings date?
Unfortunately, Bruker's (BRKR) next earnings date is currently unknown.
-
Does Bruker pay dividends?
Yes, Bruker pays dividends and its trailing 12-month yield is 0.34% with 10% payout ratio. The last Bruker stock dividend of $0.04 was paid on 17 Dec 2021.
-
How much money does Bruker make?
Bruker has a market capitalization of 8.65B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 17.14% to 2.96B US dollars.
-
What is Bruker's stock symbol?
Bruker Corporation is traded on the NASDAQ under the ticker symbol "BRKR".
-
What is Bruker's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Bruker?
Shares of Bruker can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Bruker's key executives?
Bruker's management team includes the following people:
- Dr. Frank H. Laukien Ph.D. Chairman, Chief Executive Officer & Pres(age: 65, pay: $1,150,000)
- Dr. Mark R. Munch Ph.D. Executive Vice President and Pres of Bruker Nano Group & Bruker Nano Surfaces Division(age: 63, pay: $772,260)
- Mr. Juergen Srega Pres of Bruker CALID Group & Bruker Daltonics Division(age: 70, pay: $636,530)
- Mr. Gerald N. Herman Executive Vice President, Chief Financial Officer, Corporation Controller & Interim Head of IR(age: 67, pay: $603,020)
- Dr. Falko Busse Ph.D. Pres of Bruker BioSpin Group(age: 58, pay: $571,750)
-
How many employees does Bruker have?
As Jul 2024, Bruker employs 9,707 workers.
-
When Bruker went public?
Bruker Corporation is publicly traded company for more then 25 years since IPO on 4 Aug 2000.
-
What is Bruker's official website?
The official website for Bruker is bruker.com.
-
Where are Bruker's headquarters?
Bruker is headquartered at 40 Manning Road, Billerica, MA.
-
How can i contact Bruker?
Bruker's mailing address is 40 Manning Road, Billerica, MA and company can be reached via phone at 978 663 3660.
-
What is Bruker stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Bruker in the last 12 months, the avarage price target is $76.67. The average price target represents a 124.82% change from the last price of $34.1.
Bruker company profile:
Bruker Corporation
bruker.comExchange:
NASDAQ
Full time employees:
9,707
Industry:
Medical - Devices
Sector:
Healthcare
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
40 Manning Road
Billerica, MA 01821
Billerica, MA 01821
CIK: 0001109354
ISIN: US1167941087
CUSIP: 116794108
